Anti-aging Therapeutics Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics, Small Molecules), By Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), By Mechanism of Action, By Region, And By Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Anti-aging Therapeutics Market Snapshot Chapter 4. Global Anti-aging Therapeutics Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Molecule, Estimates & Trend Analysis 5.1. By Molecules, & Market Share, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Molecules: 5.2.1. Biologics 5.2.2. Small Molecules Chapter 6. Market Segmentation 2: By Aging Types Estimates & Trend Analysis 6.1. By Aging Types & Market Share, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Aging Types: 6.2.1. Cellular Aging 6.2.2. Immune Aging 6.2.3. Metabolic Aging 6.2.4. Other Aging Types Chapter 7. Market Segmentation 3: By Mechanism of Action Estimates & Trend Analysis 7.1. By Mechanism of Action & Market Share, 2023 & 2031 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mechanism of Action: 7.2.1. Senolytic 7.2.2. Cell Regeneration 7.2.3. mTOR inhibitor/Modulator 7.2.4. AMP-kinase/AMP Activator 7.2.5. Mitochondria Inhibitor/Modulator 7.2.6. other Mechanism of Action Chapter 8. Anti-aging Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Molecules, 2024-2031 8.1.2. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Aging Types, 2024-2031 8.1.3. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Mechanism of Action, 2024-2031 8.1.4. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031 8.2. Europe 8.2.1. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031 8.2.2. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031 8.2.3. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031 8.2.4. Europe Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031 8.3. Asia Pacific 8.3.1. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031 8.3.2. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031 8.3.3. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031 8.3.4. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031 8.4. Latin America 8.4.1. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031 8.4.2. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031 8.4.3. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031 8.4.4. Latin America Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031 8.5. Middle East & Africa 8.5.1. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031 8.5.2. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031 8.5.3. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031 8.5.4. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. AgelessRx 9.2.2. ANOVA Institute for Regenerative Medicine 9.2.3. Betterhumans 9.2.4. BioAge Labs 9.2.5. BIOPHYTIS BSA 9.2.6. bioXcellerator 9.2.7. Cambrian Biopharma 9.2.8. CytoMed Therapeutics 9.2.9. Gero.ai 9.2.10. Rejuvenate Bio 9.2.11. Rejenevie Therapeutics 9.2.12. UT Health San Antonio 9.2.13. MyMD Pharmaceuticals 9.2.14. Intervene Immune, Inc. 9.2.15. CohBar, Inc. 9.2.16. Alkahest 9.2.17. Athersys Inc 9.2.18. BHB Therapeutics 9.2.19. Biosplice 9.2.20. Cyclo Therapeutics 9.2.21. Denali Therapeutics 9.2.22. Elysium Health 9.2.23. Genome Protection 9.2.24. GenSight Biologics 9.2.25. Intervene Immune 9.2.26. Khondrian 9.2.27. Longeveron 9.2.28. LyGenesis 9.2.29. Mesoblast 9.2.30. Minovia Therapeutics 9.2.31. Mitobridge 9.2.32. Navitor Pharmaceuticals 9.2.33. NeuroTrack 9.2.34. Nuchido 9.2.35. NuSirt 9.2.36. OneSkin Technologies 9.2.37. PharmatrophiX 9.2.38. Proteostasis Therapeutics 9.2.39. Retrotope 9.2.40. Stealth Biotherapeutics 9.2.41. TA Sciences 9.2.42. Unity Biotechnology 9.2.43. Younger Phenotype 9.2.44. Other Prominent Players